These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 10828654)

  • 1. Increased cerebrospinal fluid tau protein in multiple sclerosis.
    Kapaki E; Paraskevas GP; Michalopoulou M; Kilidireas K
    Eur Neurol; 2000; 43(4):228-32. PubMed ID: 10828654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tau protein seems not to be a useful routine clinical marker of axonal damage in multiple sclerosis.
    Guimarães I; Cardoso MI; Sá MJ
    Mult Scler; 2006 Jun; 12(3):354-6. PubMed ID: 16764350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tau protein level in cerebrospinal fluid is increased in patients with early multiple sclerosis.
    Brettschneider J; Maier M; Arda S; Claus A; Süssmuth SD; Kassubek J; Tumani H
    Mult Scler; 2005 Jun; 11(3):261-5. PubMed ID: 15957504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of cerebrospinal fluid levels of lateral olfactory tract usher substance (LOTUS) with disease activity in multiple sclerosis.
    Takahashi K; Kurihara Y; Suzuki Y; Goshima Y; Tanaka F; Takei K
    JAMA Neurol; 2015 Feb; 72(2):176-9. PubMed ID: 25437093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis.
    Teunissen CE; Iacobaeus E; Khademi M; Brundin L; Norgren N; Koel-Simmelink MJ; Schepens M; Bouwman F; Twaalfhoven HA; Blom HJ; Jakobs C; Dijkstra CD
    Neurology; 2009 Apr; 72(15):1322-9. PubMed ID: 19365053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CSF inflammation and axonal damage are increased and correlate in progressive multiple sclerosis.
    Romme Christensen J; Börnsen L; Khademi M; Olsson T; Jensen PE; Sørensen PS; Sellebjerg F
    Mult Scler; 2013 Jun; 19(7):877-84. PubMed ID: 23178691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab.
    Gunnarsson M; Malmeström C; Axelsson M; Sundström P; Dahle C; Vrethem M; Olsson T; Piehl F; Norgren N; Rosengren L; Svenningsson A; Lycke J
    Ann Neurol; 2011 Jan; 69(1):83-9. PubMed ID: 21280078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Axonal damage markers in the cerebrospinal fluid of patients with clinically isolated syndrome improve predicting conversion to definite multiple sclerosis.
    Brettschneider J; Petzold A; Junker A; Tumani H
    Mult Scler; 2006 Apr; 12(2):143-8. PubMed ID: 16629417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tau protein in cerebrospinal fluid: a possible marker of poor outcome in patients with early relapsing-remitting multiple sclerosis.
    Martínez-Yélamos A; Saiz A; Bas J; Hernandez JJ; Graus F; Arbizu T
    Neurosci Lett; 2004 Jun; 363(1):14-7. PubMed ID: 15157986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid tau protein is not a biological marker in amyotrophic lateral sclerosis.
    Paladino P; Valentino F; Piccoli T; Piccoli F; La Bella V
    Eur J Neurol; 2009 Feb; 16(2):257-61. PubMed ID: 19138331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tau protein concentrations in cerebrospinal fluid of patients with multiple sclerosis.
    Jiménez-Jiménez FJ; Zurdo JM; Hernanz A; Medina-Acebrón S; de Bustos F; Barcenilla B; Sayed Y; Ayuso-Peralta L
    Acta Neurol Scand; 2002 Dec; 106(6):351-4. PubMed ID: 12460140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CSF levels of total-tau and phosphotau in patients with relapsing-remitting multiple sclerosis.
    Bartosik-Psujek H; Stelmasiak Z
    J Neural Transm (Vienna); 2006 Mar; 113(3):339-45. PubMed ID: 15997419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tau protein and 14-3-3 are elevated in the cerebrospinal fluid of patients with multiple sclerosis and correlate with intrathecal synthesis of IgG.
    Bartosik-Psujek H; Archelos JJ
    J Neurol; 2004 Apr; 251(4):414-20. PubMed ID: 15083285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain-Specific Cytoskeletal Damage Markers in Cerebrospinal Fluid: Is There a Common Pattern between Amyotrophic Lateral Sclerosis and Primary Progressive Multiple Sclerosis?
    Abdelhak A; Junker A; Brettschneider J; Kassubek J; Ludolph AC; Otto M; Tumani H
    Int J Mol Sci; 2015 Jul; 16(8):17565-88. PubMed ID: 26263977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid total tau protein levels in patients with multiple sclerosis.
    Terzi M; Birinci A; Cetinkaya E; Onar MK
    Acta Neurol Scand; 2007 May; 115(5):325-30. PubMed ID: 17489943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein biomarkers for multiple sclerosis: semi-quantitative analysis of cerebrospinal fluid candidate protein biomarkers in different forms of multiple sclerosis.
    Avsar T; Korkmaz D; Tütüncü M; Demirci NO; Saip S; Kamasak M; Siva A; Turanli ET
    Mult Scler; 2012 Aug; 18(8):1081-91. PubMed ID: 22252467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tau protein concentrations in cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Jiménez-Jiménez FJ; Hernánz A; Medina-Acebrón S; de Bustos F; Zurdo JM; Alonso H; Puertas I; Barcenilla B; Sayed Y; Cabrera-Valdivia F
    Acta Neurol Scand; 2005 Feb; 111(2):114-7. PubMed ID: 15644071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis.
    Fainardi E; Castellazzi M; Bellini T; Manfrinato MC; Baldi E; Casetta I; Paolino E; Granieri E; Dallocchio F
    Mult Scler; 2006 Jun; 12(3):294-301. PubMed ID: 16764342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Some markers of neuronal damage in cerebrospinal fluid of multiple sclerosis patients in relapse.
    Mitosek-Szewczyk K; Gordon-Krajcer W; Flis D; Stelmasiak Z
    Folia Neuropathol; 2011; 49(3):191-6. PubMed ID: 22101952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tau protein, phosphorylated tau protein and beta-amyloid42 in the cerebrospinal fluid of multiple sclerosis patients.
    Valis M; Talab R; Stourac P; Andrys C; Masopust J
    Neuro Endocrinol Lett; 2008 Dec; 29(6):971-6. PubMed ID: 19112391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.